Table of Content

1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study

3. Executive Summary

4. Market Dynamics
4.1. Market Overview
4.2. Drivers
4.2.1. Rising Prevalence of Communicable and Non-communicable Diseases
4.2.2. Growing Awareness Regarding Early Disease Diagnosis
4.2.3. Adoption of Point-of-care Testing
4.2.4. Expanding Medical Tourism in the Region
4.3. Opportunities
4.3.1. Inclination Toward Personalized Healthcare or Personalized Medicine
4.3.2. Advancements in Genomics and Proteomics
4.4. Challenges
4.4.1. Regulatory Scenario in Latin American Countries

5. Latin America In Vitro Diagnostics Market Assessment?by Product & Solution
5.1. Overview
5.2. Reagents & Kits
5.3. Instruments
5.4. Software & Services

6. Latin America In Vitro Diagnostics Market Assessment?by Technology
6.1. Overview
6.2. Molecular Diagnostics
6.3. Point-of-Care (PoC) Diagnostics
6.4. Immunoassay/Immunochemistry
6.5. Biochemistry/Clinical Chemistry
6.6. Whole Blood Glucose Monitoring
6.7. Hematology
6.8. Microbiology
6.9. Coagulation & Hemostasis
6.10. Urinalysis
6.11. Other IVD Technologies

7. Latin America In Vitro Diagnostics Market Assessment?by Application
7.1. Overview
7.2. Infectious Diseases
7.3. Oncology
7.4. Cardiology
7.5. Diabetes
7.6. Autoimmune Disorders
7.7. Nephrology
7.8. Other Applications

8. Latin America In Vitro Diagnostics Market Assessment?by Diagnostic Approach
8.1. Overview
8.2. Lab Testing
8.3. OTC/Self-testing
8.4. Point-of-care Testing

9. Latin America In Vitro Diagnostics Market Assessment?by End User
9.1. Overview
9.2. Hospitals & Clinics
9.3. Diagnostic Laboratories
9.4. Home Healthcare
9.5. Other End Users

10. Latin America In Vitro Diagnostics Market Assessment?by Country
10.1. Overview
10.2. Brazil
10.3. Mexico
10.4. Argentina
10.5. Colombia
10.6. Peru
10.7. Chile
10.8. Ecuador
10.9. Uruguay
10.10. Dominican Republic
10.11. Paraguay
10.12. Bolivia
10.13. Rest of Latin America

11. Competition Analysis
11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Market Share Analysis (2022)
11.4.1. F. Hoffmann-La Roche Ltd (Switzerland)
11.4.2. Abbott Laboratories (U.S.)
11.4.3. Danaher Corporation (U.S.)

12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
12.1. Abbott Laboratories
12.2. Becton, Dickinson and Company
12.3. bioM?rieux SA
12.4. Danaher Corporation
12.5. F. Hoffmann-La Roche Ltd.
12.6. QIAGEN N.V.
12.7. Siemens Healthineers AG (A Subsidiary of Siemens AG)
12.8. Thermo Fisher Scientific, Inc.
12.9. Wama Diagn?stica
12.10. Wiener Laboratorios SAIC

13. Appendix
13.1. Available Customization
13.2. Related Reports



List of Figures

List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Latin America In Vitro Diagnostics Market, by Product & Solution, 2023 Vs. 2030 (USD Million)
Figure 8 Latin America In Vitro Diagnostics Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 9 Latin America In Vitro Diagnostics Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 10 Latin America In Vitro Diagnostics Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 11 Latin America In Vitro Diagnostics Market, by Country/Region
Figure 12 Market Dynamics
Figure 13 Latin America In Vitro Diagnostics (IVD) Market, by Product & Solution, 2023–2030 (USD Million)
Figure 14 Latin America In Vitro Diagnostics Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 15 Adult Population (20–79 Years) with Diabetes in Latin American Countries (Million) (2021)
Figure 16 Latin America In Vitro Diagnostics Market, by Application, 2023–2030 (USD Million)
Figure 17 Latin America: Estimated Number of New Cancer Cases (2020–2040)
Figure 18 Diabetes Prevalence in the South and Central America Region
Figure 19 Latin America In Vitro Diagnostics Market, by Diagnostic Approach, 2023–2030 (USD Million)
Figure 20 Benefits of Lab Testing Approach
Figure 21 Benefits of Point-of-care Testing Approach
Figure 22 Latin America In Vitro Diagnostics Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 23 Latin America In Vitro Diagnostics Market: Snapshot
Figure 24 Brazil In Vitro Diagnostics Market: Challenges
Figure 25 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 26 Latin America In Vitro Diagnostics Market: Competitive Benchmarking
Figure 27 Market Share Analysis: Latin America In Vitro Diagnostics Industry, 2022
Figure 28 Abbott Laboratories: Financial Overview (2022)
Figure 29 Becton, Dickinson and Company: Financial Overview (2022)
Figure 30 bioM?rieux SA: Financial Overview (2022)
Figure 31 Danaher Corporation: Financial Overview (2022)
Figure 32 F. Hoffmann-La Roche Ltd.: Financial Overview (2022)
Figure 33 QIAGEN N.V.: Financial Overview
Figure 34 Siemens Healthineers AG: Financial Overview (2022)
Figure 35 Thermo Fisher Scientific, Inc.: Financial Overview (2022)